Kodiak Sciences Statistics
Share Statistics
Kodiak Sciences has 52.62M shares outstanding. The number of shares has increased by 0.31% in one year.
| Shares Outstanding | 52.62M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.15% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 48.64M |
| Failed to Deliver (FTD) Shares | 287 |
| FTD / Avg. Volume | 0.08% |
Short Selling Information
The latest short interest is 1.30M, so 2.47% of the outstanding shares have been sold short.
| Short Interest | 1.30M |
| Short % of Shares Out | 2.47% |
| Short % of Float | 2.67% |
| Short Ratio (days to cover) | 5.19 |
Valuation Ratios
The PE ratio is -0.61 and the forward PE ratio is -1.34.
| PE Ratio | -0.61 |
| Forward PE | -1.34 |
| PS Ratio | 0 |
| Forward PS | 741 |
| PB Ratio | 0.6 |
| P/FCF Ratio | -0.81 |
| PEG Ratio | n/a |
Enterprise Valuation
Kodiak Sciences Inc. has an Enterprise Value (EV) of -.
| EV / Earnings | null |
| EV / Sales | null |
| EV / EBITDA | null |
| EV / EBIT | null |
| EV / FCF | null |
Financial Position
The company has a current ratio of 6.93, with a Debt / Equity ratio of 0.
| Current Ratio | 6.93 |
| Quick Ratio | 6.93 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | -21332.38 |
Financial Efficiency
Return on equity (ROE) is -0.98% and return on capital (ROIC) is -79.82%.
| Return on Equity (ROE) | -0.98% |
| Return on Assets (ROA) | -0.54% |
| Return on Capital (ROIC) | -79.82% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -2.35M |
| Employee Count | 111 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 181.73% in the last 52 weeks. The beta is 2.25, so Kodiak Sciences 's price volatility has been higher than the market average.
| Beta | 2.25 |
| 52-Week Price Change | 181.73% |
| 50-Day Moving Average | 5.14 |
| 200-Day Moving Average | 3.84 |
| Relative Strength Index (RSI) | 66.02 |
| Average Volume (20 Days) | 343.33K |
Income Statement
In the last 12 months, Kodiak Sciences had revenue of $0 and earned -$260.49M in profits. Earnings per share was $-4.97.
| Revenue | 0 |
| Gross Profit | -25.95M |
| Operating Income | -277.32M |
| Net Income | -260.49M |
| EBITDA | -259.02M |
| EBIT | - |
| Earnings Per Share (EPS) | -4.97 |
Balance Sheet
The company has $285.51M in cash and $81.63M in debt, giving a net cash position of $203.88M.
| Cash & Cash Equivalents | 285.51M |
| Total Debt | 81.63M |
| Net Cash | 203.88M |
| Retained Earnings | -1.15B |
| Total Assets | 372.67M |
| Working Capital | 178.43M |
Cash Flow
In the last 12 months, operating cash flow was -$154.18M and capital expenditures -$41.43M, giving a free cash flow of -$195.61M.
| Operating Cash Flow | -154.18M |
| Capital Expenditures | -41.43M |
| Free Cash Flow | -195.61M |
| FCF Per Share | -3.73 |
Margins
Gross margin is 0%, with operating and profit margins of 0% and 0%.
| Gross Margin | 0% |
| Operating Margin | 0% |
| Pretax Margin | 0% |
| Profit Margin | 0% |
| EBITDA Margin | n/a% |
| EBIT Margin | n/a% |
| FCF Margin | n/a% |
Dividends & Yields
KOD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -58.61% |
| FCF Yield | -43.83% |
Analyst Forecast
The average price target for KOD is $4, which is -52.8% lower than the current price. The consensus rating is "Hold".
| Price Target | $4 |
| Price Target Difference | -52.8% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
Stock Splits
The last stock split was on Feb 23, 2022. It was a forward split with a ratio of 5:1.
| Last Split Date | Feb 23, 2022 |
| Split Type | forward |
| Split Ratio | 5:1 |
Scores
| Altman Z-Score | -4.54 |
| Piotroski F-Score | 2 |